COVID-19 Pandemic-related Changes in the Child Tax Credit and Effects on Behavioral Health for Medicaid-enrolled Adolescents

与 COVID-19 大流行相关的儿童税收抵免变化及其对参加医疗补助的青少年行为健康的影响

基本信息

  • 批准号:
    10686628
  • 负责人:
  • 金额:
    $ 146.43万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2023
  • 资助国家:
    美国
  • 起止时间:
    2023-05-02 至 2026-04-30
  • 项目状态:
    未结题

项目摘要

ABSTRACT Adolescent behavioral health was already in crisis prior to the COVID-19 pandemic and has only worsened. Pandemic-related changes to the 2021 Child Tax Credit (CTC) offered financial relief to disadvantaged families. The changes were historic; the amount of refundable credit per child more than doubled, families with no or very low income were no longer excluded, and half the credit was paid through advance monthly payments (July-December 2021). Increased household income is a modifiable social determinant of health that could improve adolescent mental health through reduced household stressors. We hypothesize that compared to adolescents who were not age-eligible for the CTC, the additional CTC advance payments for age-eligible adolescents will lower their risk for adverse behavioral health events. We also expect that the CTC provided enabling resources for vulnerable adolescents with major depressive disorders (MDD) to continue treatment. The goals of the proposed study are to examine the effects of the CTC advance payments on adolescent behavioral health and treatment engagement through an innovative, quasi-experimental design (difference-in- differences, DID) and concurrent mixed-methods approach. For Aim 1, DID will compare effects before, during, and after the CTC advance payment period (1/2021-6/2021, 7/2021-12/2021, and 1/2022-9/2022) for two age groups: 1) adolescents who turned 18 fourth quarter of 2021 (not eligible for 2021 CTC advance payment), and 2) adolescents who turned 18 first quarter of 2022 (eligible). We will use two data sources to conduct these analyses from a state and national perspective: 1) Ohio Medicaid ACO (n=10,521), and 2) national Medicaid T-MSIS Analytic Files (n=972,000). Our Aim 1 outcomes include a) adverse behavioral health events (deliberate self-harm, psychiatric crisis, alcohol/drug poisoning) in emergency department/inpatient setting, and mortality (suicide, all-cause); and b) outpatient treatment and pharmacotherapy continuation (among adolescents with MDD). For Aim 2, we will recruit adolescents with a diagnosis of MDD and their caregivers using purposive sampling with quantitative Ohio Medicaid claims data for qualitative interviews (n=90). Interviews will explore the influence of the CTC on family financial distress, household resources, adolescent behavioral health and treatment engagement from diverse perspectives (racial/ethnic minorities and rural residents). Finally, Aim 3 will explore heterogeneity of the CTC treatment effects for racial/ethnic minorities and rural residents. The validity of our findings will be strengthened by using multiple data sources and a concurrent mixed-methods approach, including diverse perspectives from qualitative interviews and input from our stakeholder advisory group of national and state policy experts, community-based service providers, adolescent behavioral health providers, and families with lived experience. Impact. Our findings will have important implications for the effects of anti-poverty policies on mental health among vulnerable adolescents and could point to solutions for a growing mental health crisis.
摘要

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Laura Chavez其他文献

Laura Chavez的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Laura Chavez', 18)}}的其他基金

Racial/ethnic and geographic differences in pediatric tonsillectomy use: a multilevel investigation
儿科扁桃体切除术使用中的种族/民族和地理差异:多层次调查
  • 批准号:
    10621921
  • 财政年份:
    2022
  • 资助金额:
    $ 146.43万
  • 项目类别:

相似海外基金

Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
  • 批准号:
    MR/X02329X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 146.43万
  • 项目类别:
    Fellowship
Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
  • 批准号:
    MR/Y009568/1
  • 财政年份:
    2024
  • 资助金额:
    $ 146.43万
  • 项目类别:
    Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
  • 批准号:
    10090332
  • 财政年份:
    2024
  • 资助金额:
    $ 146.43万
  • 项目类别:
    Collaborative R&D
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
  • 批准号:
    MR/X021882/1
  • 财政年份:
    2024
  • 资助金额:
    $ 146.43万
  • 项目类别:
    Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
  • 批准号:
    MR/X029557/1
  • 财政年份:
    2024
  • 资助金额:
    $ 146.43万
  • 项目类别:
    Research Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
  • 批准号:
    EP/Y003527/1
  • 财政年份:
    2024
  • 资助金额:
    $ 146.43万
  • 项目类别:
    Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
  • 批准号:
    EP/Y030338/1
  • 财政年份:
    2024
  • 资助金额:
    $ 146.43万
  • 项目类别:
    Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
  • 批准号:
    2312694
  • 财政年份:
    2024
  • 资助金额:
    $ 146.43万
  • 项目类别:
    Standard Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
  • 批准号:
    24K19395
  • 财政年份:
    2024
  • 资助金额:
    $ 146.43万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Acute human gingivitis systems biology
人类急性牙龈炎系统生物学
  • 批准号:
    484000
  • 财政年份:
    2023
  • 资助金额:
    $ 146.43万
  • 项目类别:
    Operating Grants
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了